Bibliographic citations
Archi, H., Romero, R. (2022). Reacciones adversas a los fármacos antituberculosos en pacientes de un hospital nivel III de Huancayo, 2022 [Universidad Privada de Huancayo Franklin Roosevelt]. http://repositorio.uroosevelt.edu.pe/handle/20.500.14140/1246
Archi, H., Romero, R. Reacciones adversas a los fármacos antituberculosos en pacientes de un hospital nivel III de Huancayo, 2022 []. PE: Universidad Privada de Huancayo Franklin Roosevelt; 2022. http://repositorio.uroosevelt.edu.pe/handle/20.500.14140/1246
@misc{renati/691220,
title = "Reacciones adversas a los fármacos antituberculosos en pacientes de un hospital nivel III de Huancayo, 2022",
author = "Romero Ricse, Ruth Noemi",
publisher = "Universidad Privada de Huancayo Franklin Roosevelt",
year = "2022"
}
The objective was to analyze adverse reactions to antituberculosis drugs in patients of a level III hospital in Huancayo. Methodology: descriptive level, non-experimental cross-sectional design; the registration sheet was used as an instrument. The results showed that 68.8% of the 90 clinical histories were of the male gender. The drug most involved in the adverse reactions was Levofloxacin 17.3 %. Hepatobiliary disorders 83.3 % were the most frequent clinical manifestations; according to causality 38.9 % possible and according to severity 73.3 % mild. Comorbidity such as diabetes 13.3 %. In conclusion, there is a higher proportion in the male population, with probable causality and mild severity.
This item is licensed under a Creative Commons License